A 56-year-old man was hospitalized on day 209 after undergoing kidney transplantation for worsening kidney function (serum creatinine 4.2 mg/dL, baseline 2.3 mg/dL) and hydronephrosis of the transplant kidney.
| C A S E
A 56-year-old man was hospitalized on day 209 after undergoing kidney transplantation for worsening kidney function (serum cre- The early post-transplant course was complicated by urinary retention, two episodes of enterococcus urinary tract infections, and BK virus nephropathy. In the weeks following transplantation, the patient developed significant post-voiding residual volumes that required self-catheterization at least three times a day. Urodynamic studies revealed the presence of both bladder outlet obstruction
Abstract
We present a case of cytomegalovirus (CMV) native kidney nephritis and prostatitis in a CMV D+/R-kidney transplant recipient who had completed six months of CMV prophylaxis four weeks prior to the diagnosis of genitourinary CMV disease. The patient had a history of benign prostatic hypertrophy and urinary retention that re- (Figure 1A,B) . Immunohistochemical staining for polyomavirus was negative. The prostatic tissue also revealed CMV inclusions within the prostatic epithelium (Figure 2A,B) .
A biopsy of the kidney allograft was not performed. Plasma CMV DNA levels by quantitative PCR were 5322 IU/mL. Treatment for the patient's CMV genitourinary disease consisted of IV ganciclovir at induction doses adjusted for renal clearance until CMV viremia resolved, followed by maintenance dose valganciclovir for a total of 3 months. His renal function returned to baseline.
| D ISCUSS I ON
Cytomegalovirus is among the most common opportunistic infections after solid organ transplantation and a significant cause of morbidity in kidney transplantation. CMV is known to cause severe tissue-invasive disease in immunocompromised hosts, particularly pneumonitis, gastrointestinal disease, hepatitis, and, less commonly, retinitis, myocarditis, pericarditis, pancreatitis, cholecystitis, encephalitis, transverse myelitis, Guillain-Barre syndrome, and adrenalitis.
2 CMV also has a predilection for involvement in the transplant allograft, likely due to local aberrant immune responses. 3 However, invasive CMV disease of the kidney is rare, even among kidney transplant recipients. This case highlights that CMV infection may extend beyond the kidney allograft and that other parts of the genitourinary tract may also be sites for CMV disease.
Here, we report a first case of CMV involvement in the native kidney and highlight the presence of concurrent CMV prostatitis in a kidney transplant recipient. Our case illustrates the tissue risk factors of CMV disease. In addition to being at highrisk based on donor and recipient CMV serologic status (D+/R-) and induction with a lymphocyte depleting agent, our patient had numerous uroepithelial insults: pre-existing genitoureteral abnormality, delayed graft function which correlates with ischemic injury to the transplant ureter, 4 repeated mechanical microinjury from self-catheterization, and preceding or concomitant uroepithelial infections by bacteria and BK virus. Such tissue injuries result in a proinflammatory environment that is linked to CMV reactivation. 5, 6 CMV reactivates from latently infected cells under inflammatory stimuli, particularly tumor necrosis factor (TNF)-α.
TNF-α binds to TNF receptors on latently infected cells and leads to downstream nuclear factor-kB (NF-kB) activation, which translocates into the nucleus, binds to the immediate-early enhancer region of CMV, and initiates viral replication. [7] [8] [9] Reactivation of CMV is associated with elevated serum TNF-α levels in patients with sepsis, atopic dermatitis, transplant organ rejection in solid organ transplant recipients, and graft-versus-host-disease in hematopoietic cell transplant recipients. 5 Other proinflammatory mediators such as prostaglandins and stress catecholamines that act via TNF-α independent pathways have also been found to trigger viral reactivation. [10] [11] [12] Thus, local inflammation in tissues produced by traumatic, mechanical, toxic, or infectious injury, as in our patient, can promote a susceptible environment for CMV reactivation and infection.
Though several reports of CMV infection in the transplanted kidney or ureter exist, [13] [14] [15] [16] [17] [18] [19] this is a first report of CMV nephritis of the native kidney in a kidney transplant recipient. CMV infection of the native ureter was reported in one liver-kidney transplant recipient 7 years after transplantation. Notably, the patient also had preceding uroepithelial injury from bacterial pyelonephritis requiring decompression with a ureteral stent. Shortly after completing antibiotic CMV prostatitis has also been reported rarely in immunocompromised hosts, particularly among HIV-positive patients, solid organ transplant recipients, and a patient with multiple myeloma receiving chemotherapy. [21] [22] [23] [24] [25] [26] Among transplant recipients, CMV prostatitis has been reported in 3 kidney, 1 liver, and 1 heart transplant recipient (Table 1) . [21] [22] [23] Most presented with mild obstructive symptoms and elevated prostate-specific antigen several years after 
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